MKhair Alsaad
@khbenad
Cardiologist &🚨physician @ UKOWL| MD &MSc cand.|
ID: 703458674543616000
27-02-2016 05:56:32
114 Tweet
119 Takipçi
184 Takip Edilen
In patients with CCS undergoing PCI, ticagrelor monotherapy after 3 months of DAPT showed similar 1-year ischaemic and bleeding outcomes compared to ticagrelor-based #DAPT, regardless of high ischaemic risk status. Mauro Gitto ow.ly/6Afj50VYwKa #EAPCI #TWILIGHTTrial
📌 HALT after TAVI: variable response to DOACs This case-based report highlights haemodynamic valve deterioration (HVD) linked to HALT, with heterogeneous outcomes to DOAC therapy. Warfarin may be more effective in selected cases. Ali S. Husain د.علي صاحب حسين ow.ly/Kltr50WuFhU #TAVI
The REDUCER-I study showed most patients treated with the coronary sinus Reducer feel better at 1 year, with 99% procedural success and low complication rates. But questions remain: how does it work, and who benefits most? 👉 Read the editorial by Rasha Al-Lamee and M.J. Foley
A rare OCT finding captured after acetylcholine-induced spasm, resolving with nitroglycerine. Teresa Bastante 📖 Read the full case here 👇 eurointervention.pcronline.com/article/erosio…
In patients undergoing #PCI, a personalized #DAPT duration from 3 to 24 months led to a lowered risk of net adverse clinical events than standard care consisting of 12 months of DAPT. jacc.org/doi/10.1016/j.… #JACC #ESCCongress #WCCardio Raffaele Piccolo Davide Capodanno
PULSE Results: CCTA following #PCI for unprotected LM disease did 🚫 ⬇️ the composite risk of major adverse CV events at 18 months. CCTA was associated w/ fewer spontaneous MIs & more imaging-triggered revasc. bit.ly/4n7hHvy #cvImaging JACC Journals #JACC #ESCCongress
#JACCIMG state-of-the-art review on #cvImaging in #vhdTR: Advanced imaging has played an essential role in the rapid advancement of Dx & management of tricuspid regurgitation. jacc.org/doi/10.1016/j.… Maurice Sarano Victoria Delgado RTHahnMD Luigi João Cavalcante Fabien Praz
Left bundle branch area pacing for atrioventricular block improved survival compared to right ventricular pacing. Read the results of the MELOS RELOADED study 👉 ow.ly/H70t50X0G4E Rocco Montone EHJ Editor-in-Chief